|
|
Article: Examine the Stakeholder Opinions: Celiac Disease - Licensing Opportunities Exist in Untapped Market.
- Article from:
- Biotech Week
- Article date:
- May 13, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Reportlinker.com announces that a new market research report is available in its catalogue. Stakeholder Opinions: Celiac Disease - Licensing opportunities exist in untapped market http://www.reportlinker.com/p0116589/Stakeholder-Opinions-Celiac-Disease---Licensing-opportunities-exist-in-untapped-market.html Introduction Low disease awareness, poor diagnosis rates, combined with a lack of pharmaceutical industry involvement, has kept celiac disease from the limelight. However, this is changing as evidenced by Shire's recent involvement in the pipeline. Datamonitor believes a drug for celiac disease is up to 5 years away and this untapped gastrointestinal indication has the ...